The first embryonic stem (ES) cell trial for severe heart failure is launching now in Paris.
.jpg)
The long-awaited trial comes after much preclinical cell work on more than 350 rats, 50 immunodeficient mice and 32 non-human primates.
“After 20 years in the stem cell area and a daily practice of cardiac surgery, I am very cautiously optimistic,” Principle Investigator Philippe Menasche told Bioscience Technology. Menasche is chief of the Heart Failure Surgery Unit of the Hôpital Européen Georges Pompidou, and director of an INSERM (France’s National Institute of Health and Medical Research) lab devoted to cell therapy of cardiovascular diseases.
“These patients are, by definition, very sick. I hope the trial will be just a step from which we can learn how to move the field forward,” he said.
You can read more about this story using this link:
http://www.biosciencetechnology.com/articles/2014/10/world-first-embryonic-stem-cell-trial-heart
You can read more about this story using this link:
http://www.biosciencetechnology.com/articles/2014/10/world-first-embryonic-stem-cell-trial-heart
No comments:
Post a Comment